Osaic Holdings’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $268K | Buy |
5,872
+792
| +16% | +$36.1K | ﹤0.01% | 3359 |
|
2025
Q1 | $204K | Sell |
5,080
-669
| -12% | -$26.9K | ﹤0.01% | 3606 |
|
2024
Q4 | $259K | Buy |
5,749
+260
| +5% | +$11.7K | ﹤0.01% | 3371 |
|
2024
Q3 | $290K | Buy |
5,489
+2,974
| +118% | +$157K | ﹤0.01% | 3344 |
|
2024
Q2 | $136K | Sell |
2,515
-268
| -10% | -$14.5K | ﹤0.01% | 3881 |
|
2024
Q1 | $195K | Sell |
2,783
-3,776
| -58% | -$265K | ﹤0.01% | 3711 |
|
2023
Q4 | $548K | Sell |
6,559
-376
| -5% | -$31.4K | ﹤0.01% | 3084 |
|
2023
Q3 | $204K | Buy |
6,935
+1,474
| +27% | +$43.4K | ﹤0.01% | 3977 |
|
2023
Q2 | $184K | Buy |
5,461
+274
| +5% | +$9.25K | ﹤0.01% | 3953 |
|
2023
Q1 | $182K | Sell |
5,187
-99
| -2% | -$3.48K | ﹤0.01% | 3941 |
|
2022
Q4 | $242K | Sell |
5,286
-4,347
| -45% | -$199K | ﹤0.01% | 3687 |
|
2022
Q3 | $467K | Sell |
9,633
-15,553
| -62% | -$754K | ﹤0.01% | 2962 |
|
2022
Q2 | $992K | Buy |
25,186
+19,256
| +325% | +$758K | ﹤0.01% | 2274 |
|
2022
Q1 | $154K | Buy |
5,930
+767
| +15% | +$19.9K | ﹤0.01% | 4236 |
|
2021
Q4 | $235K | Buy |
5,163
+979
| +23% | +$44.6K | ﹤0.01% | 3798 |
|
2021
Q3 | $151K | Buy |
4,184
+87
| +2% | +$3.14K | ﹤0.01% | 4163 |
|
2021
Q2 | $83K | Buy |
4,097
+196
| +5% | +$3.97K | ﹤0.01% | 4642 |
|
2021
Q1 | $92K | Buy |
3,901
+1,176
| +43% | +$27.7K | ﹤0.01% | 4399 |
|
2020
Q4 | $55K | Buy |
2,725
+1,342
| +97% | +$27.1K | ﹤0.01% | 4472 |
|
2020
Q3 | $33K | Hold |
1,383
| – | – | ﹤0.01% | 4579 |
|
2020
Q2 | $33K | Sell |
1,383
-106
| -7% | -$2.53K | ﹤0.01% | 4444 |
|
2020
Q1 | $18K | Buy |
+1,489
| New | +$18K | ﹤0.01% | 4655 |
|